Mission Possible – Delivering translational impact
More than 360 participants: speakers, researchers, clinicians, patients, sponsors, and other cancer research specialists gathered in Little Finlandia (Helsinki) on…
More than 360 participants: speakers, researchers, clinicians, patients, sponsors, and other cancer research specialists gathered in Little Finlandia (Helsinki) on…
The International Chronic Myeloid Leukemia Foundation (iCMLf) has announced that Professor Satu Mustjoki, Scientific Director of the iCAN – Digital Precision…
The Jane and Aatos Erkko Foundation has announced its latest round of research funding – a highly competitive call where…
Mitä syöpään sairastuneena tai läheisenä haluaisit kertoa syöpätutkijalle? Mikä on se ongelma, joka sinua eniten huolettaa syöpään ja hoitoihin liittyen,…
We are pleased to announce the appointment of Mariike Kuijjer, who took on the role of Director of the iCANDOC…
Our first-ever iCAN Studyathon, an initiative focused on metastatic non-small cell lung cancer (mNSCLC) and the real-life impact of immune checkpoint inhibitor (ICIs) therapy, took…
The first-ever iCANDOC national get-together gathered doctoral researchers and their supervisors from all five participating universities. The event provided an…
The Faculty of Medicine, University of Helsinki awarded the best Master’s theses of 2024 at a ceremony on Friday, March 21, 2025, at Biomedicum. The award for the TRANSMED – Master’s Programme in Translational Medicine was presented to a iCANDOC Doctoral Researcher Srividhya Sundaresan.
Finnish Cancer Center FICAN is looking for a Senior Planning Officer to play a key role in two national projects aimed…
An international study led by researchers from the University of Helsinki highlights the role of natural killer cells in aplastic…
End of content
End of content